Abstract:Endometrial cancer presents a major public health issue, particularly in post-menopausal women. Whilst there are known risk factors for the disease, including oestrogen and obesity, these factors do not fully explain risk variability in cancer outcomes. The identification of novel risk factors may aid in better understanding of endometrial cancer development and, given the link with oestrogen metabolism, obesity and the risk of various cancers, the gut microbiome could be one such risk factor. Mendelian randomization (MR), a method that reduces biases of conventional epidemiological studies (namely, confounding and reverse causation) by using genetic variants to proxy exposures, was used to investigate the effect of gut microbial traits on endometrial cancer risk. Whilst our initial analyses showed that the presence of an unclassified group of bacteria in the family increased the risk of oestrogen-dependent endometrial cancer (odds ratio (OR) per approximate doubling of the genetic liability to presence vs absence: 1.13; 95% CI: 1.01, 1.26; P=0.03), subsequent sensitivity analyses, including colocalisation, suggested these findings were unlikely reflective of causality. This work highlights the importance of using a robust MR analysis pipeline, including sensitivity analyses to assess the validity of causal effect estimates obtained using MR.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the causal role of the human gut microbiome in the development of endometrial cancer. Specifically, the researchers used the Mendelian randomization (MR) method, with genetic variation as a proxy variable, to evaluate the impact of gut microbial characteristics on the risk of endometrial cancer. This method aims to reduce the influence of confounding factors and reverse causality common in traditional epidemiological studies, thereby more accurately estimating the potential causal relationship between the gut microbiome and endometrial cancer. ### Research Background Endometrial cancer is a major public health problem, especially more common among post - menopausal women. Known risk factors include estrogen and obesity, but these factors cannot fully explain the variability in cancer risk. Therefore, identifying new risk factors is crucial for better understanding the development mechanism of endometrial cancer. Given the associations between the gut microbiome and estrogen metabolism, obesity, and the risk of multiple cancers, the researchers believe that the gut microbiome may be a new risk factor for endometrial cancer. ### Research Objectives The main objective of the study was to use the two - sample Mendelian randomization method, combined with the current largest genome - wide association study (GWAS) data, to evaluate the causal impact of specific gut microbial characteristics on the risk of endometrial cancer. To ensure the reliability of the results, the researchers also conducted a variety of sensitivity analyses to evaluate the validity of the MR assumptions. ### Research Methods 1. **Data Sources**: - **Gut Microbiome GWAS Data**: From three independent European cohorts (Flemish Gut Flora Project, FGFP; FoCus; PopGen), including a total of 3,890 participants. - **Endometrial Cancer GWAS Data**: Aggregated data from 17 studies, including a total of 12,906 endometrial cancer cases and 108,979 controls, among which there are 8,758 endometrioid cancer cases and 1,230 non - endometrioid cancer cases. 2. **Genetic Tool Selection**: - Thirteen single - nucleotide polymorphisms (SNPs) that reached the genome - wide significance threshold (p < 5×10^-8) were selected from the microbiome GWAS, and each SNP was associated with an independent microbial characteristic. - An additional SNP associated with Bifidobacterium bacteria was selected, which was consistently reported in multiple microbiome GWAS. 3. **Mendelian Randomization Analysis**: - Using the two - sample MR method, combined with the above - mentioned GWAS data, the causal effects of 14 microbial characteristics on the risk of endometrial cancer were evaluated. - A variety of sensitivity analyses were carried out, including horizontal pleiotropy detection, using a more relaxed p - value threshold to select genetic tools, using anti - pleiotropy methods (such as MR - Egger, weighted median and weighted mode), colocalization analysis, and reverse MR analysis. ### Main Findings - **Preliminary Analysis**: It was found that the presence of unclassified Erysipelotrichaceae bacteria increased the risk of estrogen - dependent endometrial cancer (OR = 1.13, 95% CI: 1.01, 1.26, P = 0.03). - **Sensitivity Analysis**: Subsequent sensitivity analyses, including colocalization analysis and anti - pleiotropy methods, indicated that the preliminary findings may be affected by horizontal pleiotropy and are unlikely to reflect the true causal relationship. ### Conclusion Although the preliminary analysis showed that unclassified Erysipelotrichaceae bacteria may increase the risk of estrogen - dependent endometrial cancer, the results of the sensitivity analysis indicate that this finding may be interfered by other factors, especially horizontal pleiotropy. Therefore, the study emphasizes the importance of using a strict analysis pipeline and sensitivity analysis in Mendelian randomization studies to ensure the reliability and accuracy of the results.

Exploring the causal role of the human gut microbiome in endometrial cancer: a Mendelian randomization approach

Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study

Associations between gut microbiota and gynecological cancers: A bi-directional two-sample Mendelian randomization study

Mendelian randomization analysis revealed a gut microbiota–mammary axis in breast cancer

Causal relationship between gut microbiota and gynecological tumor: a two-sample Mendelian randomization study

Causal effects of gut microbiome on endometriosis: a two-sample mendelian randomization study

Genetically predicted blood metabolites mediate relationships between gut microbiota and ovarian cancer: a Mendelian randomization study

Mendelian randomization analysis to investigate the gut microbiome in oral and oropharyngeal cancer

Association between gut microbiota and gastric cancers: a two-sample Mendelian randomization study

Table S8 from Exploring the Complex Relationship Between Gut Microbiota and Risk of Colorectal Neoplasia Using Bidirectional Mendelian Randomization Analysis

Table S6 from Exploring the Complex Relationship Between Gut Microbiota and Risk of Colorectal Neoplasia Using Bidirectional Mendelian Randomization Analysis

Causal association of gut microbiota and esophageal cancer: a Mendelian randomization study

Gut microbiome and reproductive endocrine diseases: a Mendelian randomization study

Mendelian randomization unraveled: gender-specific insights into obesity-related phenotypes and colorectal cancer susceptibility

A Large Genetic Causal Analysis of the Gut Microbiota and Urological Cancers: A Bidirectional Mendelian Randomization Study

Revealing a causal relationship between gut microbiota and lung cancer: a Mendelian randomization study

Genetically identification of endometriosis and cancers risk in women through a two-sample Mendelian randomization study

Unraveling the relationship between gut microbiota and site-specific endometriosis: a Mendelian randomization analysis

Association between gut microbiota and gastrointestinal cancer: a two-sample bi-directional Mendelian randomization study

Dissecting the association between gut microbiota and liver cancer in European and East Asian populations using Mendelian randomization analysis

Causal association between gut microbiota and hyperemesis gravidarum: a two-sample Mendelian randomization study